findmyKOL

Marc Goldschmidt, MD

Basic profile

Stony Brook School

ORCIDNone on fileNPI
RegionStony Brook, NY · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Marc Goldschmidt is a Cardiology physician affiliated with Stony Brook School. OpenAlex indexes 5 publications with 291 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
5publications

Distinct works indexed by OpenAlex.

291citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
27companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Stony Brook University Hhs Center T16-030
Stony Brook, NY 117946136

Telephone

631-444-3278

Provider last certified this registry record 21 Jun 2021.

View the NPPES registry record

Industry payments

27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    74.8%
    Beta blocker19.1%
    Carvedilol56%Metoprolol Succinate33%Bisoprolol Fumarate12%
    Part D52 patients
    Loop diuretic12.1%
    Torsemide88%Furosemide12%
    Part D<11 patients

    + 9 more classes in this area

  • Metabolism & gastrointestinal

    15.9%
    SGLT2 inhibitor14.5%
    Jardiance81%Farxiga19%
    Part D60 patients
    Proton pump inhibitor1.4%
    Pantoprazole Sodium100%
    Part D<11 patients
  • Blood & clotting

    6.5%
    Factor Xa inhibitor5.6%
    Eliquis50%Xarelto50%
    Part D17 patients
    P2Y12 inhibitor1%
    Clopidogrel100%
    Part D<11 patients
Where care is delivered (Part B)32.6% facility · 67.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”